Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Información selecta para pacientes y cuidadores que se encuentra disponible en Español.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PREPIDIL®How Supplied/Storage and Handling (dinoprostone)

HOW SUPPLIED

PREPIDIL Gel is available as a sterile semitranslucent viscous preparation for endocervical application: 0.5 mg PGE2 per 3.0 g (2.5 mL) in syringe. In addition, each package contains two shielded catheters (10 mm and 20 mm tip) enclosed in sterile envelopes. The contents are not guaranteed sterile if envelopes are not intact.

Each 3 gram syringe applicator contains:
dinoprostone, 0.5 mg; colloidal silicon dioxide, 240 mg; triacetin, 2760 mg.

1 × 3 gram syringeNDC 0009-3359-01
5 × 3 gram syringesNDC 0009-3359-02

PREPIDIL Gel needs to be stored under continuous refrigeration (36° to 46°F; 2° to 8°C).

Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event